These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 33984486

  • 1. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D, Yang W, Zeng Y, Li W, Wang K, Zhao L, Li J, Ye Y, Guo Q.
    Cell Signal; 2021 Aug; 84():110038. PubMed ID: 33984486
    [Abstract] [Full Text] [Related]

  • 2. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
    Han Y, Ma Z.
    Anticancer Drugs; 2021 Apr 01; 32(4):427-436. PubMed ID: 33587348
    [Abstract] [Full Text] [Related]

  • 3. Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p/SENP2/PI3K/AKT/mTOR axis.
    Jiang Y, Xiao S, Huang S, Zhao X, Ding S, Huang Q, Xiao W, Li Z, Zhu H.
    Hematology; 2024 Dec 01; 29(1):2379597. PubMed ID: 39056503
    [Abstract] [Full Text] [Related]

  • 4. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
    Nie ZY, Yao M, Yang Z, Yang L, Liu XJ, Yu J, Ma Y, Zhang N, Zhang XY, Liu MH, Jiang LL, Luo JM.
    J Exp Clin Cancer Res; 2020 Jan 17; 39(1):17. PubMed ID: 31952546
    [Abstract] [Full Text] [Related]

  • 5. LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis.
    Dai H, Wang J, Huang Z, Zhang H, Wang X, Li Q, Feng W.
    Technol Cancer Res Treat; 2021 Jan 17; 20():15330338211052150. PubMed ID: 34723728
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2.
    Deng Y, Li X, Feng J, Zhang X.
    Biosci Rep; 2018 Jun 29; 38(3):. PubMed ID: 29559564
    [Abstract] [Full Text] [Related]

  • 7. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells.
    Chen PH, Liu AJ, Ho KH, Chiu YT, Anne Lin ZH, Lee YT, Shih CM, Chen KC.
    Chem Biol Interact; 2018 Aug 01; 291():144-151. PubMed ID: 29890129
    [Abstract] [Full Text] [Related]

  • 8. Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia.
    Cao HX, Miao CF, Sang LN, Huang YM, Zhang R, Sun L, Jiang ZX.
    Life Sci; 2020 Feb 15; 243():117255. PubMed ID: 31923418
    [Abstract] [Full Text] [Related]

  • 9. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
    Hekmatshoar Y, Ozkan T, Altinok Gunes B, Bozkurt S, Karadag A, Karabay AZ, Sunguroglu A.
    Cell Mol Biol (Noisy-le-grand); 2018 May 15; 64(6):23-30. PubMed ID: 29808796
    [Abstract] [Full Text] [Related]

  • 10. circ_0080145 Enhances Imatinib Resistance of Chronic Myeloid Leukemia by Regulating miR-326/PPFIA1 Axis.
    Che H, Ding H, Jia X.
    Cancer Biother Radiopharm; 2024 Sep 15; 39(7):478-491. PubMed ID: 32598170
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
    Lin TY, Chen KC, Liu HJ, Liu AJ, Wang KL, Shih CM.
    PLoS One; 2016 Sep 15; 11(5):e0156260. PubMed ID: 27228340
    [Abstract] [Full Text] [Related]

  • 12. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
    Farhadi E, Zaker F, Safa M, Rezvani MR.
    Tumour Biol; 2016 Oct 15; 37(10):14117-14128. PubMed ID: 27517565
    [Abstract] [Full Text] [Related]

  • 13. circCRKL, a circRNA derived from CRKL, regulates BCR-ABL via sponging miR-877-5p to promote chronic myeloid leukemia cell proliferation.
    Wang J, Liang Y, Qin Y, Jiang G, Peng Y, Feng W.
    J Transl Med; 2022 Sep 04; 20(1):395. PubMed ID: 36058922
    [Abstract] [Full Text] [Related]

  • 14. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
    Lan X, Zhao C, Chen X, Zhang P, Zang D, Wu J, Chen J, Long H, Yang L, Huang H, Carter BZ, Wang X, Shi X, Liu J.
    J Hematol Oncol; 2016 Nov 25; 9(1):129. PubMed ID: 27884201
    [Abstract] [Full Text] [Related]

  • 15. Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.
    Bhutra S, Lenkala D, LaCroix B, Ye M, Huang RS.
    PLoS One; 2014 Nov 25; 9(12):e115003. PubMed ID: 25506832
    [Abstract] [Full Text] [Related]

  • 16. MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia.
    Liu YY, Jiao WY, Li T, Bao YY.
    Eur Rev Med Pharmacol Sci; 2019 Oct 25; 23(19):8468-8475. PubMed ID: 31646577
    [Abstract] [Full Text] [Related]

  • 17. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
    Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Raanani P, Shpilberg O, Granot G.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):597-605. PubMed ID: 25305453
    [Abstract] [Full Text] [Related]

  • 18. HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis.
    Chen X, Chen Y, Zhang M, Cheng H, Mai H, Yi M, Xu H, Yuan X, Liu S, Wen F.
    Cell Death Dis; 2022 Jan 28; 13(1):92. PubMed ID: 35091542
    [Abstract] [Full Text] [Related]

  • 19. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
    Ferreira AF, Moura LG, Tojal I, Ambrósio L, Pinto-Simões B, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA.
    Blood Cells Mol Dis; 2014 Jan 28; 53(1-2):47-55. PubMed ID: 24629639
    [Abstract] [Full Text] [Related]

  • 20. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
    Salati S, Salvestrini V, Carretta C, Genovese E, Rontauroli S, Zini R, Rossi C, Ruberti S, Bianchi E, Barbieri G, Curti A, Castagnetti F, Gugliotta G, Rosti G, Bergamaschi M, Tafuri A, Tagliafico E, Lemoli R, Manfredini R.
    Oncotarget; 2017 Jul 25; 8(30):49451-49469. PubMed ID: 28533480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.